Brief: Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology
15/12/2025 12:19
Dec 15 (Reuters) - Cencora Inc COR.N: CENCORA OUTLOOK FY ADJUSTED EPS USD 17.45-17.75 CENCORA - TO BUY MAJORITY STAKE IN ONEONCOLOGY CENCORA - ONEONCOLOGY VALUED AT $7.4 BILLION IN DEAL CENCORA - TO BUY STAKE IN ONEONCOLOGY FOR $3.6 BILLION CENCORA - TO FUND DEAL WITH NEW DEBT FINANCING CENCORA - RAISES LONG-TERM GUIDANCE FOR ADJUSTED OPERATING INCOME AND ADJUSTED EPS CENCORA - EXPECTS DEAL TO BE ABOUT NEUTRAL, NET OF FINANCING COSTS, TO CO'S ADJUSTED DILUTED EPS IN FIRST TWELVE MONTHS FOLLOWING CLOSE CENCORA OUTLOOK LONG-TERM ADJUSTED OPERATING INCOME 7% TO 10% CENCORA - IN ANTICIPATION OF COMPANY'S ACQUISITION OF ONEONCOLOGY, IT IS PAUSING SHARE REPURCHASES CENCORA - MORE LIKELY COMPANY'S FULL YEAR ADJUSTED DILUTED EPS WILL BE TOWARDS LOWER HALF OF ITS GUIDANCE RANGE OF $17.45 TO $17.75 CENCORA - SEES LONG-TERM ADJUSTED DILUTED EARNINGS PER SHARE UP 10% TO 14% CENCORA - REITERATES FISCAL 2026 GUIDANCE Source text: ID:nBw2p6Db2a Further company coverage: COR.N ((Reuters.Briefs@thomsonreuters.com;))